{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:57:58Z","timestamp":1781323078199,"version":"3.54.1"},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7032-25","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:09:40Z","timestamp":1781129380000},"source":"Crossref","is-referenced-by-count":0,"title":["Relative importance of weight gain among cardiometabolic risk factors in the development of metabolic dysfunction-associated steatotic liver disease: An observational study using large-scale health examination data"],"prefix":"10.2169","author":[{"given":"Kazuki","family":"Sahara","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Hiraiwa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Ishizu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuhito","family":"Kojima","sequence":"additional","affiliation":[{"name":"Aichi Health Promotion Foundation, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyoshi","family":"Kariya","sequence":"additional","affiliation":[{"name":"Aichi Health Promotion Foundation, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Kawashima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Henry L, Paik J, Younossi ZM. Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world. Aliment Pharmacol Ther 56 (6): 942-956, 2022.","DOI":"10.1111\/apt.17158"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ito T, Ishigami M, Zou B, et al. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040. Hepatol Int 15 (2): 366-379, 2021.","DOI":"10.1007\/s12072-021-10143-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mantovani A, Csermely A, Petracca G, et al. Non-alcoholic fatty liver disease and increased risk of fatal and nonfatal cardiovascular events: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol 6 (11): 903-913, 2021.","DOI":"10.1016\/S2468-1253(21)00308-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Byrne CD, Targher G. NAFLD: A multisystem disease. J Hepatol 62 (1): 47-64, 2015.","DOI":"10.1016\/j.jhep.2014.12.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 79 (6): 1542-1556, 2023.","DOI":"10.1097\/HEP.0000000000000696"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tacke F, Horn P, Wong VWS, et al. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol 81 (3): 492-542, 2024.","DOI":"10.1016\/j.jhep.2024.04.031"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kanwal F, Neuschwander-Tetri BA, Loomba R, et al. Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology 79 (5): 1212-1219, 2024.","DOI":"10.1097\/HEP.0000000000000670"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Targher G, Valenti L, Byrne CD. Metabolic Dysfunction-Associated Steatotic Liver Disease. N Engl J Med 393 (7): 683-698, 2025.","DOI":"10.1056\/NEJMra2412865"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Targher G, Byrne CD, Tilg H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73 (4): 691-702, 2024.","DOI":"10.1136\/gutjnl-2023-330595"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Younossi ZM, Corey KE, Lim JK. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology 160 (3): 912-918, 2021.","DOI":"10.1053\/j.gastro.2020.11.051"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Hagstr\u00f6m H, et al. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical. J Hepatol 80 (2): 76-77, 2024.","DOI":"10.1016\/j.jhep.2023.08.026"},{"key":"12","unstructured":"12. Ministry of Health, Labour and Welfare. Standardized health check-up and health guidance program. Tokyo; 2018 [Internet]. Available from: https:\/\/www.mhlw.go.jp\/content\/10900000\/001603146.pdf"},{"key":"13","unstructured":"13. World Health Organization. WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020 [Internet]. [cited 2026 May 19]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240015128"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 102 (12): 2708-2715, 2007.","DOI":"10.1111\/j.1572-0241.2007.01526.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"14. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver diseas. J Hepatol 64 (6): 1388-1402, 2016.","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Hernaez R, Lazo M, Bonekamp S, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology 54 (3): 1082-1090, 2011.","DOI":"10.1002\/hep.24452"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang X, Wong GLH, Yip TCF, et al. Risk of liver-related events by age and diabetes duration in patients with diabetes and nonalcoholic fatty liver disease. Hepatology 76 (5): 1409-1422, 2022.","DOI":"10.1002\/hep.32476"},{"key":"18","unstructured":"18. Japanese Committee for Clinical Laboratory Standards (JCCLS). Common reference intervals for clinical laboratory tests in Japan. Tokyo: JCCLS 2022 (in Japanese)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kanda Y. Investigation of the freely available easy-to-use software &quot;EZR&quot; for medical statistics. Bone Marrow Transplant 48 (3): 452-458, 2013.","DOI":"10.1038\/bmt.2012.244"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Wong VWS, Wong GLH, Chan RSM, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol 69 (6): 1349-1356, 2018.","DOI":"10.1016\/j.jhep.2018.08.011"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. Hepatol Res 51 (10): 1013-1025, 2021.","DOI":"10.1111\/hepr.13688"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Guilherme A, Virbasius JV, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9 (5): 367-377, 2008.","DOI":"10.1038\/nrm2391"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Lomonaco R, Ortiz-Lopez C, Orsak B, et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 55 (5): 1389-1397, 2012.","DOI":"10.1002\/hep.25539"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Chang Y, Ryu S, Sung E, et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut 58 (10): 1419-1425, 2009.","DOI":"10.1136\/gut.2008.161885"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Zelber-Sagi S, Lotan R, Shlomai A, et al. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 56 (5): 1145-1151, 2012.","DOI":"10.1016\/j.jhep.2011.12.011"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yamada G, Hagiwara Y, Kimura T, et al. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals. Am J Gastroenterol 116 (4): 733-740, 2021.","DOI":"10.14309\/ajg.0000000000001030"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kimura T, Deshpande GA, Urayama KY, et al. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals. J Gastroenterol Hepatol 30 (5): 909-917, 2015.","DOI":"10.1111\/jgh.12861"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Parr CL, Batty GD, Lam TH, et al. Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration. Lancet Oncol 11 (8): 741-752, 2010.","DOI":"10.1016\/S1470-2045(10)70141-8"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Hubert HB, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (5): 968-977, 1983.","DOI":"10.1161\/01.CIR.67.5.968"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chen C, Ye Y, Zhang Y, et al. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ 367: l5584, 2019.","DOI":"10.1136\/bmj.l5584"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Mantovani A, Byrne CD, Bonora E, et al. Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: A meta-analysis. Diabetes Care 41 (2): 372-382, 2018.","DOI":"10.2337\/dc17-1902"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jarvis H, Craig D, Barker R, et al. Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. PLoS Med 17 (4): e1003100, 2020.","DOI":"10.1371\/journal.pmed.1003100"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Miyake T, Furukawa S, Matsuura B, et al. Glycemic control is associated with histological findings of nonalcoholic fatty liver disease. Diabetes Metab J 48 (3): 440-448, 2024.","DOI":"10.4093\/dmj.2023.0200"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Handley D, Gillett AC, Bala R, et al. Latent class growth mixture modeling of HbA1c trajectories identifies individuals at high risk of developing complications of type 2 diabetes mellitus in the UK Biobank. BMJ Open Diabetes Res Care 13 (5): e004826, 2025.","DOI":"10.1136\/bmjdrc-2024-004826"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nishioji K, Mochizuki N, Kobayashi M, et al. The impact of PNPLA3 rs738409 genetic polymorphism and weight gain \u226510 kg after age 20 on non-alcoholic fatty liver disease in non-obese Japanese individuals. PLoS One 10 (10): e0140427, 2015.","DOI":"10.1371\/journal.pone.0140427"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7032-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T03:48:59Z","timestamp":1781322539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7032-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7032-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7032-25"}}